MAI Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
16,267
+1,831
+13% +$17.7K ﹤0.01% 1718
2026
Q1
$107K Sell
14,436
-59
-0.4% -$621 ﹤0.01% 1794
2025
Q4
$170K Sell
14,495
-150
-1% -$1.62K ﹤0.01% 1383
2025
Q3
$113K Buy
14,645
+5
+0% +$35 ﹤0.01% 1508
2025
Q2
$107K Sell
14,640
-50
-0.3% -$404 ﹤0.01% 1448
2025
Q1
$139K Sell
14,690
-725
-5% -$9.05K ﹤0.01% 1263
2024
Q4
$254K Hold
15,415
﹤0.01% 1052
2024
Q3
$227K Hold
15,415
﹤0.01% 967
2024
Q2
$214K Hold
15,415
﹤0.01% 1125
2024
Q1
$242K Hold
15,415
﹤0.01% 1053
2023
Q4
$249K Sell
15,415
-250
-2% -$4.09K ﹤0.01% 934
2023
Q3
$193K Hold
15,665
﹤0.01% 971
2023
Q2
$252K Hold
15,665
﹤0.01% 882
2023
Q1
$273K Sell
15,665
-3,507
-18% -$50K ﹤0.01% 834
2022
Q4
$177K Buy
19,172
+1,930
+11% +$18K ﹤0.01% 919
2022
Q3
$148K Sell
17,242
-684
-4% -$6.79K ﹤0.01% 864
2022
Q2
$146K Buy
17,926
+668
+4% +$6.38K ﹤0.01% 817
2022
Q1
$210K Buy
17,258
+1,645
+11% +$34.6K ﹤0.01% 813
2021
Q4
$533K Sell
15,613
-8,670
-36% -$340K 0.01% 559
2021
Q3
$1.17M Buy
24,283
+14
+0.1% +$648 0.02% 343
2021
Q2
$1.1M Buy
24,269
+11,193
+86% +$496K 0.02% 342
2021
Q1
$631K Sell
13,076
-1,000
-7% -$52.1K 0.01% 431
2020
Q4
$758K Buy
14,076
+66
+0.5% +$2.98K 0.02% 376
2020
Q3
$517K Buy
+14,010
New +$521K 0.02% 394

Other funds holding NEO

MAI Capital Management's NEO Position: Q2 2026 in Review

MAI Capital Management increased its NeoGenomics (NEO) stake by 13% in Q2 2026, buying an estimated $17.7K and bringing the position to 16,267 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

MAI Capital Management first reported a position in NEO in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.17M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • MAI Capital Management held 16,267 shares of NeoGenomics worth $237K as of Q2 2026.
  • MAI Capital Management bought 1,831 NeoGenomics shares in Q2 2026, an estimated $17.7K.
  • NeoGenomics made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1718 holding.
  • MAI Capital Management first reported a position in NeoGenomics in Q3 2020 and has held it in 24 quarters since.
  • MAI Capital Management's NeoGenomics position peaked at $1.17M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.